Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Study Completion Date

August 31, 2004

Conditions
Colorectal Neoplasms
Interventions
DRUG

tezacitabine

DRUG

oxaliplatin

Trial Locations (8)

20007

Georgetown University Medical Center, Lombardi Cancer Center, Washington D.C.

60611

Northwestern University Feinberg School of Medicine, Chicago

64111

Kansas City Oncology and Hematology Group, Kansas City

85712

ACRC/Arizona Clinical Research Center, Tucson

90033

USC/Norris Comprehensive Cancer Center, Los Angeles

90404

Cancer Institute Medical Group, Santa Monica

92262

Comprehensive Cancer Centers of the Desert, Palm Springs

33612-9497

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Chiron Corporation

INDUSTRY